BioPharma APAC counts 12 generic makers since Novo's patent lapsed in March. Some vials run about Rs 1,300 a month, and generics hit half of sales by April.
Recap by typeshit. Full story at BioPharma APAC.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Holly Lofton and Jennifer Manne-Goehler say safety looks similar to other GLP-1s so far, and Lofton reports gray market patients who saw no weight loss at all.
Medscape reports the finding on nail separation, while experts quoted say more research is needed and caution doctors against alarming patients.
Loading…